DNA News and Research

RSS
Stanford researchers discover tissue-specific target in pathogen

Stanford researchers discover tissue-specific target in pathogen

New insights into yeast cells may help identify cancer cells and stem cells development: Study

New insights into yeast cells may help identify cancer cells and stem cells development: Study

Amgen announces results from pivotal Phase 3 "408" trial of Vectibix

Amgen announces results from pivotal Phase 3 "408" trial of Vectibix

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Study shows long-term effect of vitamins and calcium supplements in breast cancer reduction

Study shows long-term effect of vitamins and calcium supplements in breast cancer reduction

Teen drinking increases the risk for breast cancer

Teen drinking increases the risk for breast cancer

MedImmune to present ten abstracts at American Association for Cancer Research meeting

MedImmune to present ten abstracts at American Association for Cancer Research meeting

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

NSF Faculty Early Career Development Award for Zhihao Zhuang

NSF Faculty Early Career Development Award for Zhihao Zhuang

Illumina announces first named family DNA sequence

Illumina announces first named family DNA sequence

Researchers receive honorary Doctor of Medicine degrees

Researchers receive honorary Doctor of Medicine degrees

GeoVax Labs Labs announces 1-for-50 reverse stock split

GeoVax Labs Labs announces 1-for-50 reverse stock split

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

DNA modification can define early onset glioblastoma

DNA modification can define early onset glioblastoma

RUCDR is poised to become a world leader in human disease and genome studies

RUCDR is poised to become a world leader in human disease and genome studies

Positive interim data from Idera Pharmaceuticals' Phase 1 trial of IMO-2125 TLR9 agonist presented at 45th EASL

Positive interim data from Idera Pharmaceuticals' Phase 1 trial of IMO-2125 TLR9 agonist presented at 45th EASL

Embryos with two mums to remove the risk of hereditary diseases: new research

Embryos with two mums to remove the risk of hereditary diseases: new research

Trans-urethral prostate hyperthermia treatment offers 100% response rate

Trans-urethral prostate hyperthermia treatment offers 100% response rate

Certain genetic variations linked to tooth decay, periodontitis

Certain genetic variations linked to tooth decay, periodontitis

Findings shed light on pathogenesis behind human mitochondrial encephalomyopathies

Findings shed light on pathogenesis behind human mitochondrial encephalomyopathies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.